Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee weighs bill to authorize autologous and directed blood donations; Vitalant warns of safety and cost risks
Summary
Representatives presented House Bill 135 to authorize and regulate autologous and directed blood donations; Vitalant and transfusion specialists urged caution, citing safety, waste and resource concerns and proposed technical amendments. The committee did not vote.
House Bill 135, a measure authorizing and regulating autologous (self‑donation) and direct (donation for a named recipient) blood donations, was presented to the Labor, Health & Social Services Committee and drew split reaction from witnesses.
Representative Joel Guggenmos and co‑introducer Sarah Penn told the committee HB 135 would create a statutory framework for autologous and directed donations, set minimum requirements for hospitals and blood banks, allow reasonable facilitation and storage fees, and direct the Wyoming Department of Health to adopt implementing rules.
Vitalant, the region’s primary blood collector, said the bill as drafted would reduce safety, divert limited nonprofit blood‑center resources and…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
